- Previous Close
2,930.00 - Open
2,942.00 - Bid 2,920.00 x --
- Ask 2,922.00 x --
- Day's Range
2,913.00 - 2,951.00 - 52 Week Range
2,142.50 - 3,094.00 - Volume
88,948 - Avg. Volume
117,051 - Market Cap (intraday)
11.067B - Beta (5Y Monthly) 0.58
- PE Ratio (TTM)
3,842.11 - EPS (TTM)
0.76 - Earnings Date --
- Forward Dividend & Yield 0.22 (0.76%)
- Ex-Dividend Date Dec 19, 2024
- 1y Target Est
--
Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
www.halma.comRecent News: HLMAL.XC
View MorePerformance Overview: HLMAL.XC
Trailing total returns as of 2/21/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HLMAL.XC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HLMAL.XC
View MoreValuation Measures
Market Cap
10.99B
Enterprise Value
11.64B
Trailing P/E
38.61
Forward P/E
29.94
PEG Ratio (5yr expected)
3.61
Price/Sales (ttm)
5.12
Price/Book (mrq)
6.33
Enterprise Value/Revenue
5.39
Enterprise Value/EBITDA
22.89
Financial Highlights
Profitability and Income Statement
Profit Margin
13.28%
Return on Assets (ttm)
8.72%
Return on Equity (ttm)
16.90%
Revenue (ttm)
2.16B
Net Income Avi to Common (ttm)
286.5M
Diluted EPS (ttm)
0.76
Balance Sheet and Cash Flow
Total Cash (mrq)
180.2M
Total Debt/Equity (mrq)
47.51%
Levered Free Cash Flow (ttm)
302.09M